Tango Therapeutics

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

cancer

Biotech

News

Health Care

General

TNGX

Tango Therapeutics halts its TNG348 program due to liver toxicity issues found in dose escalation studies. The company will now focus on its PRMT5 program and plans to update on TNG908 and TNG462 later this year.

Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

CENX

CTKB

ITOS

METC

OLMA

SAVA

SMMT

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Wyndham Hotels &amp; Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday

Intraday Update

ALDX

ALHC

AMAM

BIOC

BNTX

BPTH

CBIO

CDLX

CLOV

CNSL

CNSP

ELYS

ENSC

EPIX

ETWO

EXTO

FAZE

INDI

LULU

MANU

MLTX

MNTS

MODD

MREO

NAOV

NFTG

NOTV

NVAX

OMER

OSTK

PCSA

PCTI

PIXY

PROC

PRTA

PRZO

RDHL

RERE

RVLP

SASI

SECO

SNAP

STRM

Tempest Therapeutics, Inc. - Common Stock

TPST

VSTO

YGMZ

ZAPP

Gainers


	MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.


Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Tango Therapeutics Inc

Press Releases

Tango Therapeutics to Participate in Upcoming Investor Conferences

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics to Present at the Guggenheim SMID Cap Biotechnology Conference

Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences

Earnings

Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Highlights

Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025

Barbara Weber, M.D., Elected to ITM Supervisory Board

RLAY

RVMD

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Annexon

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cellectis S.A. - American Depositary Shares

Cellectis

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Kodiak Sciences

Korro Bio

Lyell Immunopharma

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nanobiotix

Neurogene

Nkarta

Puma Biotechnology

Prime Medicine

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

Regulus Therapeutics

Rezolute

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

HC Wainwright & Co.

B. Riley Securities

Guggenheim

Wedbush

Jefferies

Comments

Tango Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell